Neuphoria Therapeutics (NEUP) Receivables (2020 - 2026)
Neuphoria Therapeutics (NEUP) posted Receivables of $1.62 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with $11,948 a year earlier and down 32.7% from the prior quarter.
Neuphoria Therapeutics (NEUP) Receivables (2020 - 2026) Analysis & Trends
Since fiscal Q4 2020, Neuphoria Therapeutics has reported Receivables for 13 quarters.
- Annual Receivables shows a five-year compound annual growth rate of 0.5% (FY2021 to FY2026).
- In prior fiscal years, Neuphoria Therapeutics' Receivables was $11,948 in FY2025 (-94.6%), $223,038 in FY2024 (-73.7%), $848,708 in FY2023 (-91.2%) and $9.67 million in FY2022 (+510.8%).
- Quarterly Receivables has run from a low of $1,758 in fiscal Q1 2026 to a high of $4.86 million in fiscal Q4 2022 over five years.
- According to Business Quant data, Receivables for the three prior fiscal quarters was $2.41 million (Q3 2026), $1.6 million (Q2 2026) and $1,758 (Q1 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Neuphoria Therapeutics | 443.79 Mn | 368.60 Mn | - | 1.62 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.62 Mn |
| Mar 31, 2026 | 2.41 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1,758.00 |
| Jun 30, 2025 | 11,948.00 |
| Mar 31, 2025 | 24,592.00 |
| Dec 31, 2024 | 35,561.00 |
| Sep 30, 2024 | 216,585.00 |
| Jun 30, 2024 | 223,038.00 |
| Jun 30, 2023 | 429,272.54 |
| Jun 30, 2022 | 4.86 Mn |
| Jun 30, 2021 | 868,841.66 |
| Jun 30, 2020 | 1.19 Mn |
Neuphoria Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=NEUP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();